FIELD: medicine, pathophysiology, experimental cardiology.
SUBSTANCE: one should narcotize rats and intraperitonealy inject the tested medicinal preparation at a single therapeutic dosage, perform continuous ECG registration, subcutaneously introduce 0.1 ml of 0.1%-adrenaline hydrochloride solution. In 2-3 d animal should be "lifted" for compression chamber height of 11000 m to continue the survey under conditions of acute height hypoxia for 10 min. In case of segment ST shift observed at ECG or rhythm or conductivity disoders one should state upon the inefficiency of pharmacological protection under hypoxic conditions. The absence of the above-mentioned alterations is the sign of the efficiency of pharmacological cardioprotection. The method enables to simply and efficiently evaluate the efficiency of pharmacological cardioprotection.
EFFECT: higher efficiency of evaluation.
59 dwg, 10 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR MODELING ISCHEMIC MYOCARDIAL LESION IN RATS | 2002 |
|
RU2243595C2 |
METHOD FOR DETERMINING INDIVIDUAL HYPOXIA RESISTANCE OF ANIMALS | 2002 |
|
RU2217043C2 |
METHOD OF PROPHYLAXIS AND TREATMENT OF PATIENT WITH MYOCARDIUM ISCHEMIA IN CORONARY-INVASIVE OPERATIONS | 1999 |
|
RU2146933C1 |
METHOD FOR MODELING ACUTE MYOCARDIAL INFARCTION IN ANIMALS | 2020 |
|
RU2750354C1 |
METHOD FOR INCREASING BODY RESISTANCE TO ACUTE HYPOXIA IN EXPERIMENT | 2017 |
|
RU2649126C1 |
METHOD FOR INCREASING BODY RESISTANCE TO ACUTE HYPOXIA IN EXPERIMENT | 2013 |
|
RU2517032C1 |
AGENT INCREASING STABILITY AGAINST STRESS | 0 |
|
SU1813446A1 |
3-(2-DIETHYLAMINOETHYLAMINO)-1,2,4-TRIAZINO/6,5/INDOLE HYDROCHLORIDE HAVING ANTIINFLAMMATORY ACTIVITY AND INCREASING PHYSICAL RESISTANCE OF ORGANISM AGAINST HYPOXIA | 1981 |
|
SU1014249A1 |
AGENT POSSESSING ANTIARRHYTHMIC ACTION | 2019 |
|
RU2700263C1 |
ANTI-ISHEMIC AND ANTIHYPOXIC AGENT | 2007 |
|
RU2356573C1 |
Authors
Dates
2004-12-27—Published
2002-11-28—Filed